IC
TYRA icon

Ikarian Capital’s Tyra Biosciences TYRA Stock Holding History

Ikarian Capital’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-35,000
Closed -$326K – 191
2025
Q1 		$326K Sell
35,000
-25,000
-42% -$324K 0.04% 126
2024
Q4 		$834K Buy
+60,000
New +$1.09M 0.11% 115
2024
Q2 		– Sell
-501
Closed -$8.22K – 154
2024
Q1 		$8.22K Sell
501
-47,669
-99% -$782K ﹤0.01% 135
2023
Q4 		$667K Hold
48,170
– – 0.06% 110
2023
Q3 		$663K Hold
48,170
– – 0.08% 104
2023
Q2 		$820K Hold
48,170
– – 0.13% 87
2023
Q1 		$774K Buy
+48,170
New +$573K 0.18% 85

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $76.1M AUM 638.59% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Ikarian Capital's TYRA Position: Q2 2025 in Review

Ikarian Capital sold out of Tyra Biosciences (TYRA) in Q2 2025, closing a stake of 35,000 shares — an estimated $326K sold.

Ikarian Capital first reported a position in TYRA in Q1 2023 and held it in 7 quarters. The position peaked at $834K in Q4 2024. 121 funds tracked by Wall St. Rank hold TYRA as of Q2 2025.

  • Ikarian Capital reported no remaining Tyra Biosciences position as of Q2 2025 after selling out during the quarter.
  • Ikarian Capital sold 35,000 Tyra Biosciences shares in Q2 2025, an estimated $326K.
  • Ikarian Capital first reported a position in Tyra Biosciences in Q1 2023 and held it in 7 quarters.
  • Ikarian Capital's Tyra Biosciences position peaked at $834K in Q4 2024.
  • 121 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2025.

Based on Ikarian Capital's 13F filing for Q2 2025, filed 14 Aug 2025.